Melatonin Protects Against Colistin‐Induced Intestinal Inflammation and Microbiota Dysbiosis DOI

Yuqian Jia,

Tingting Zhang,

Mengping He

et al.

Journal of Pineal Research, Journal Year: 2024, Volume and Issue: 76(5)

Published: July 8, 2024

ABSTRACT Colistin is renowned as a last‐resort antibiotic due to the emergence of multidrug‐resistant pathogens. However, its potential toxicity significantly hampers clinical utilization. Melatonin, chemically known N ‐acetyl‐5‐hydroxytryptamine, an endogenous hormone produced by pineal gland and possesses diverse biological functions. protective role melatonin in alleviating antibiotic‐induced intestinal inflammation remains unknown. Herein, we reveal that colistin stimulation markedly elevates inflammatory levels compromises gut barrier. In contrast, pretreatment with safeguards mice against mucosal damage. Microbial diversity analysis indicates supplementation prevents reduction abundance Erysipelotrichales Bifidobacteriales , well increase Desulfovibrionales abundance, following exposure. Remarkably, short‐chain fatty acids (SCFAs) shows propanoic acid contributes effect on colistin‐induced inflammation. Furthermore, protection effects LPS‐induced cellular RAW 264.7 cells are confirmed. Mechanistic investigations suggest intervention can repress activation TLR4 signal downstream NF‐κB MAPK signaling pathways, thereby mitigating toxic colistin. Our work highlights unappreciated preventing detrimental health suggests combined therapeutic strategy effectively manage infectious diseases.

Language: Английский

Tailored Beta‐Lapachone Nanomedicines for Cancer‐Specific Therapy DOI
Yaru Li,

Meiyu Feng,

Tao Guo

et al.

Advanced Healthcare Materials, Journal Year: 2023, Volume and Issue: 12(20)

Published: March 27, 2023

Abstract Nanotechnology shows the power to improve efficacy and reduce adverse effects of anticancer agents. As a quinone‐containing compound, beta‐lapachone (LAP) is widely employed for targeted therapy under hypoxia. The principal mechanism LAP‐mediated cytotoxicity believed due continuous generation reactive oxygen species with aid NAD(P)H: quinone oxidoreductase 1 (NQO1). cancer selectivity LAP relies on difference between NQO1 expression in tumors that healthy organs. Despite this, clinical translation faces problem narrow therapeutic window challenging dose regimen design. Herein, multifaceted briefly introduced, advance nanocarriers delivery reviewed, combinational approaches enhance potency recent years are summarized. mechanisms by which nanosystems boost efficacy, including tumor targeting, cellular uptake enhancement, controlled cargo release, enhanced Fenton or Fenton‐like reaction, multidrug synergism, also presented. problems nanomedicines prospective solutions discussed. current review may help unlock potential cancer‐specific speed up its translation.

Language: Английский

Citations

16

Nitric Oxide‐Based Nanomedicines for Conquering TME Fortress: Say “NO” to Insufficient Tumor Treatment DOI

Yuting Xiang,

Qiaohui Chen,

Yayun Nan

et al.

Advanced Functional Materials, Journal Year: 2023, Volume and Issue: 34(13)

Published: Dec. 21, 2023

Abstract Almost all cancer treatments are significantly limited by the strong tumor microenvironment (TME) fortress formed abnormal vasculature, dense extracellular matrix (ECM), multidrug resistance (MDR) system, and immune “cold” environment. In huge efforts of dismantling TME fortress, nitric oxide (NO)‐based nanomedicines increasingly occupying a central position have already been identified as super “strong polygonal warriors” to dismantle for efficient treatment, benefiting from NO's unique physicochemical properties extremely fascinating biological effects. However, there is paucity systematic review elaborate on progress fundamental mechanism NO‐based in oncology this aspect. Herein, key characteristics potential NO reprogramming delineated highlighted. The evolution donors advantages discussed subsequently. Moreover, latest solid tumors comprehensively reviewed, including normalizing overcoming ECM barrier, reversing MDR, reactivating immunosuppression TME. Lastly, prospects, limitations, future directions manipulation provide new insights into construction more applicable anticancer nanomedicines.

Language: Английский

Citations

16

Trinitroglycerin-loaded chitosan nanogels: Shedding light on cytotoxicity, antioxidativity, and antibacterial activities DOI

Khatereh Asadi,

Reza Heidari, Mehrdad Hamidi

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 265, P. 130654 - 130654

Published: March 29, 2024

Language: Английский

Citations

5

Photothermal-controlled NO-releasing Nanogels reverse epithelial-mesenchymal transition and restore immune surveillance against cancer metastasis DOI
Junmei Zhang,

Guizhi Miao,

My Hanh Ta

et al.

Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 371, P. 16 - 28

Published: May 22, 2024

Language: Английский

Citations

5

State-of-the-Art and Perspectives for Nanomaterials Combined with Nitric Oxide Donors: From Biomedical to Agricultural Applications DOI
Joana Claudio Pieretti,

Milena T. Pelegrino,

Neidiquele M. Silveira

et al.

ACS Applied Nano Materials, Journal Year: 2023, Volume and Issue: 7(16), P. 18590 - 18609

Published: Oct. 20, 2023

The free radical nitric oxide (NO) is a signaling molecule that controls several important physiological and pathophysiological processes in mammals plants. In humans, the biological impacts of NO include, but are not limited to, key roles cardiovascular, neurological, immunological, respiratory, reproductive systems. plants, modulates plant growth development with defense against biotic abiotic stress conditions. However, administration exogenous donors still faces limitations, mainly due to their instability lack bioavailability system. Recently, combination nanomaterials has been extensively explored as promising strategy tailor spatiotemporal release therapeutic amounts NO. Nanoscience offers smart approaches deliver on demand for particular application. Although this shown results, scientific studies less agricultural applications compared biomedical research. current review summarizes impact research emphasizes recent progress nanotechnology donors. advantages, challenges, drawbacks discussed light inspiring exciting topic, aiming translate these innovations into clinical/practical settings.

Language: Английский

Citations

11

Potential therapeutic applications of medical gases in cancer treatment DOI Creative Commons
Abbas Al Bazzal, Bassel H. Hoteit, Mariam Chokor

et al.

Medical Gas Research, Journal Year: 2025, Volume and Issue: 15(2), P. 309 - 317

Published: Jan. 18, 2025

Medical gases were primarily used for respiratory therapy and anesthesia, which showed promising potential in the cancer therapy. Several physiological pathological processes affected by key gases, such as oxygen, carbon dioxide, nitric oxide, hydrogen sulfide, monoxide. Oxygen targets shrinking tumor via hyperbaric oxygen therapy, once combined with radiation it enhances its effect. Nitric oxide has both anti- pro-tumor effects depending on level; at high doses, triggers cell death while low doses supports growth. The same concept is applied to sulfide promotes growth enhancing mitochondrial bioenergetics supporting angiogenesis concentrations, concentrations induces sparing normal cells. Furthermore, dioxide helps induce apoptosis improve oxygenation treatments increasing release of from hemoglobin. Moreover, high-dose monoxide gas demonstrated significant reductions vivo supported nanomedicine specialized medicines boost delivery cells availability peroxide. Despite potentials these several challenges remain. Gas should be regulated balance anti-tumor sulfide. effective systems, nanoparticles, developed targeted

Language: Английский

Citations

0

Recent advancement in the anticancer efficacy of the natural flavonoid scutellarin: a comprehensive review DOI Creative Commons

Deena Elsori,

Pratibha Pandey, Meenakshi Verma

et al.

Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16

Published: March 27, 2025

Scutellarin (SC), a natural flavonoid, has been expansively employed in treating innumerable inflammation-related diseases due to its antitumor, antiinflammatory, anticancer, and antioxidant potential. can inhibit significant inflammatory cell signaling pathways, comprisingPI3K/Akt, NF-κB, MAPK, while activating antioxidant-related pathways such as Nrf2 ARE. Numerous reviews have outlined scutellarin’s pharmacological effects associated mechanisms diseases. Several studies elucidated the of anticancer activity by inhibiting various pathways; however, our knowledge, none distinguished potential scutellarin based on different human cancer types. Our review detailed insights about type body. Furthermore, we also formulations, combinatorial therapies, comprehensive mechanistic research deliver enhanced effective treatment options for patients. This study will provide thorough into scutellarin, supporting development promising candidate treatment.

Language: Английский

Citations

0

Application of Non-Pharmacologic Therapy in Hair Loss Treatment and Hair Regrowth DOI Creative Commons

Xinlyu Huang,

Pengxiang Zhao,

Gu-Xue Zhang

et al.

Clinical Cosmetic and Investigational Dermatology, Journal Year: 2024, Volume and Issue: Volume 17, P. 1701 - 1710

Published: July 1, 2024

Alopecia significantly affects the appearance and psychology of patients, pharmacological therapies hair transplantation are main treatments for alopecia, but both have limitations. This review aimed to summarize non-pharmacological that promote growth regeneration.

Language: Английский

Citations

3

Carbon monoxide gas molecules: Therapeutic mechanisms in radiation-induced lung injury DOI
Yanan Li, Bingshuai Zhou,

Deyang Liu

et al.

Journal of Colloid and Interface Science, Journal Year: 2025, Volume and Issue: 688, P. 250 - 263

Published: Feb. 21, 2025

Language: Английский

Citations

0

sEmerging glucose oxidase-delivering nanomedicines for enhanced tumor therapy DOI

Kai‐Yue Song,

Ming Jiang, Bailong Tao

et al.

Journal of Controlled Release, Journal Year: 2025, Volume and Issue: 381, P. 113580 - 113580

Published: Feb. 28, 2025

Language: Английский

Citations

0